The receipt of this permission paves way for the launch of Dapagliflozin (Forxiga) tablets of 10 mg in India for the specified additional/expanded indication, subject to the receipt of related statutory approvals
Viehbacher brings extensive international experience in large pharmaceutical and entrepreneurial biotech companies
The decision follows authorization from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) in May 2022.
CEPI will provide seed funding of up to US$2.5 million to Codiak BioSciences.
AstraZeneca also played a critical role in the global response to COVID-19.
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
Pioneering Medicines and Novo Nordisk Bio Innovation Hub will leverage Flagship Pioneering’s bioplatform companies to create a portfolio of research programmes within cardiometabolic and rare diseases
Pharmapack trends are a key barometer of global device and packing opportunities in 2022
This collaboration strengthens Akron’s portfolio of off-the-shelf gene-editing technologies while broadening Vor Bio’s collection of nucleases to engineer gene-modified cell therapies
Companies plan to commercialize breath-based detection of lung infection and transplant rejection
Subscribe To Our Newsletter & Stay Updated
